NDC 0093-7487-19 - Montelukast Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0093-7487
- Requested NDC
- 0093-7487-19
- Package NDCs from labels
- 0093-7487-19, 0093-7487-56
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Effective date
- 2021-05-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Montelukast Sodium - Teva Pharmaceuticals USA, Inc. | Teva Pharmaceuticals USA, Inc. | 2021-05-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-7487-19 | EA - Each | 0093-7487 | ee113742-0e03-42e2-ae71-dfd372fc85a8 | 1 | 2018-01-12 |
| 0093-7487-56 | EA - Each | 0093-7487 | 360488ce-c5c5-4e72-99f3-e8eccca8c231 | 1 | 2018-01-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Montelukast | MONTELUKAST | XLCare Pharmaceuticals Inc. | 82d65eea-c7c9-4e16-9176-46c43f00f0f6 | 2023-01-17 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 368GB5141J |
| Montelukast Sodium | MONTELUKAST SODIUM | Dr.Reddy's Laboratories Limited | 3d4451a9-d73d-b9de-68ec-853bfeff6e4b | 2022-10-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| montelukast sodium | MONTELUKAST SODIUM | Proficient Rx LP | 2ce48faf-4504-488a-8b20-3e8d4f008fb2 | 2022-06-01 | Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Proficient Rx LP | 97cc4e1e-e0fd-4bb5-8f9e-b8573f5230e5 | 2022-05-02 | Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | BluePoint Laboratories | 4c411d3e-47b6-481b-b846-419ed4cbb947 | 2022-03-10 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Accord Healthcare Inc. | 6eea668f-a2fa-447f-b2d5-4c754d13d9fa | 2022-01-01 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Proficient Rx LP | 83c35a3d-0bbc-4598-bf76-ab0c2903bf19 | 2021-07-01 | Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Aphena Pharma Solutions - Tennessee, LLC | 4fe3c0d4-94ff-43ca-9d24-54676fe593fe | 2021-06-26 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| 290fd46f-1364-47d5-9982-f90f1b6bbbba | ad5a77e1-cd4c-48da-8b65-f3e97433e5df | 2021-05-31 | Boxed warning, Warnings, Adverse reactions | ad5a77e1-cd4c-48da-8b65-f3e97433e5df | ||
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Proficient Rx LP | 901385e5-7384-4c28-a36a-7dd84c36f5fd | 2021-01-01 | Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Proficient Rx LP | 54014b67-3163-4c8f-b93a-229cd231ca6b | 2021-01-01 | Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Proficient Rx LP | 8a724790-e1fb-4935-bb28-ce99455be5ef | 2019-11-01 | Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST | MONTELUKAST | Proficient Rx LP | 9705627c-283e-4743-b261-cfeb88d96e9b | 2019-11-01 | Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Proficient Rx LP | 0f2dbf17-bce0-4e09-8c22-898d93be80da | 2019-11-01 | Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST | Proficient Rx LP | cab84c43-96a3-4868-88da-3126685edf00 | 2019-10-01 | Warnings, Adverse reactions | U1O3J18SFL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.